// App-Quantinova.ai

: Outcomes of Using Carbetocin as the Primary Uterotonic for Cesarean Delivery: A Prospective Study

Researchers

Presenter

  • Valerie Zaphiratos

Principal Investigators

  • Adel Alqarni

  • Christian Loubert

  • Pierre A. Drolet

  • Philippe G. Richebe

Medical Centers

  • Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Carbetocin

  • Oxytocin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved